The development and production of novel monoclonal antibodies (mAbs) requires a method to screen and isolate monoclonal antibody-producing cells. This is often achieved by performing Enzyme-Linked Immunosorbent Assays (ELISAs) on thousands of single cells, a highly laborious and resource-intensive process.
